Bionomics Limited (BNOX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 292,124.88 |
| Enterprise Value | -13.8M |
| P/E Ratio | -0.39 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | -2.22 |
| Price/Book Ratio | 0.79 |
| Enterprise/Revenue | -0.37 |
| Enterprise/EBITDA | -0.17 |
Fiscal Year
| Fiscal Year | June 30, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 2.63 |
| Operating Margin | 2.5 |
AD
Management Effectiveness
| Return On Assets | -0.79 |
| Return On Equity | -1.1 |
Income Statement
| Revenue | 0 |
| Revenue/Share | -1.94 |
| Gross Profit | -434,449 |
| EBITDA | -1.13B |
| Net Income | -369.63M |
| Diluted EPS | -41.4 |
Balance Sheet
| Total Cash | 19.44M |
| Total Cash/Share | 3.59 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 14.31 |
| Book Value Per Share | 5.44 |
Price History
| 52-Week Change | -97.97 |
| 52-Week High | 16.32 |
| 52-Week Low | 0.24 |
| Moving Average 50 Days | 3.59 |
| Moving Average 200 Days | 7.38 |
Statistics
| Average Volume | 881,890 |
| Shares Outstanding | 19.58M |
| % Held by Institutions | 8.91 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | December 24, 2024 |
AD
